Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 5694-68-8 | MDL No. : | MFCD08062572 |
Formula : | C4H8O3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | ZAGUSKAXELYWCE-UHFFFAOYSA-N |
M.W : | 104.10 | Pubchem ID : | 294864 |
Synonyms : |
|
Num. heavy atoms : | 7 |
Num. arom. heavy atoms : | 0 |
Fraction Csp3 : | 1.0 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 22.56 |
TPSA : | 38.69 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -10.3 cm/s |
Log Po/w (iLOGP) : | 1.45 |
Log Po/w (XLOGP3) : | -4.74 |
Log Po/w (WLOGP) : | -0.65 |
Log Po/w (MLOGP) : | -1.05 |
Log Po/w (SILICOS-IT) : | 0.54 |
Consensus Log Po/w : | -0.89 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 3.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | 2.57 |
Solubility : | 38400.0 mg/ml ; 369.0 mol/l |
Class : | Highly soluble |
Log S (Ali) : | 4.56 |
Solubility : | 3740000.0 mg/ml ; 35900.0 mol/l |
Class : | Highly soluble |
Log S (SILICOS-IT) : | 0.28 |
Solubility : | 199.0 mg/ml ; 1.91 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.15 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
97.3% | With hydrogen In methanol at 20℃; for 15 h; | (66b) 1,3-dioxolan-2-ylmethanol To a methanol (100 ml) solution of 2-((benzyloxy)methyl)-1,3-dioxolane (3.01 g, 15.5 mmol) obtained in the step (66a) above, palladium hydroxide (20 wt. percent Pd (dry basis) on carbon, wet (water max. 50percent))(300 mg) was added and the mixture was stirred in a hydrogen atmosphere at room temperature for 15 hours. The reaction vessel was purged with nitrogen and a catalyst was removed by filtration through celite, and then, washed with methanol. The filtrate was concentrated and dried under reduced pressure to obtain the title compound (1.57 g, 97.3percent yield) as a light yellow oil. 1H NMR(400 MHz, CDCl3) δppm; 1.89(1H, br s), 3.66-3.72(2H, m), 3.88-4.08(4H, m), 5.01(1H, t, J=3 Hz). |
[ 22323-82-6 ]
(S)-(+)-2,2-Dimethyl-1,3-dioxolane-4-methanol
Similarity: 0.67
[ 14347-78-5 ]
(R)-(2,2-Dimethyl-1,3-dioxolan-4-yl)methanol
Similarity: 0.67
[ 22323-82-6 ]
(S)-(+)-2,2-Dimethyl-1,3-dioxolane-4-methanol
Similarity: 0.67
[ 14347-78-5 ]
(R)-(2,2-Dimethyl-1,3-dioxolan-4-yl)methanol
Similarity: 0.67
[ 18742-02-4 ]
2-(2-Bromoethyl)-1,3-dioxolane
Similarity: 0.64
[ 22323-82-6 ]
(S)-(+)-2,2-Dimethyl-1,3-dioxolane-4-methanol
Similarity: 0.67
[ 14347-78-5 ]
(R)-(2,2-Dimethyl-1,3-dioxolan-4-yl)methanol
Similarity: 0.67
[ 1607-37-0 ]
4-[(2,3-Epoxypropoxy)methyl]-2,2-dimethyl-1,3-dioxolane
Similarity: 0.64